Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

[Effects of artificial microRNA targeting glucosylceramide synthase on drug sensitivity of breast cancer cells].

Sun YL, Gao P, Zhang XF, Gao YS, Zhou GY.

Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3296-9. Chinese.

PMID:
23328518
2.

[Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].

Sun YL, Zhou GY, Li KN, Li WT, Song XR, Gao P.

Zhonghua Yi Xue Za Zhi. 2005 Mar 2;85(8):518-21. Chinese.

PMID:
15949329
3.

MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

Zhong S, Li W, Chen Z, Xu J, Zhao J.

Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.

PMID:
23994196
4.

Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.

Liu YY, Han TY, Giuliano AE, Hansen N, Cabot MC.

J Biol Chem. 2000 Mar 10;275(10):7138-43.

5.
6.

Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells.

Sun YL, Zhou GY, Li KN, Gao P, Zhang QH, Zhen JH, Bai YH, Zhang XF.

Neoplasma. 2006;53(1):1-8.

PMID:
16416005
7.

MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.

Zhang X, Wu X, Li J, Sun Y, Gao P, Zhang C, Zhang H, Zhou G.

J Surg Oncol. 2011 Oct;104(5):466-71. doi: 10.1002/jso.21958. Epub 2011 May 2.

PMID:
21538359
8.

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs.

Sun Y, Zhang T, Gao P, Meng B, Gao Y, Wang X, Zhang J, Wang H, Wu X, Zheng W, Zhou G.

Breast Cancer Res Treat. 2010 Jun;121(3):591-9. doi: 10.1007/s10549-009-0513-z. Epub 2009 Aug 20.

PMID:
19693666
9.

MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.

Li XJ, Ji MH, Zhong SL, Zha QB, Xu JJ, Zhao JH, Tang JH.

Arch Med Res. 2012 Oct;43(7):514-21. doi: 10.1016/j.arcmed.2012.09.007. Epub 2012 Oct 16.

PMID:
23085450
10.

Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.

Qi X, Chang Z, Song J, Gao G, Shen Z.

Anticancer Drugs. 2011 Jul;22(6):556-62. doi: 10.1097/CAD.0b013e328345b4e7.

PMID:
21637162
11.
12.

Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.

Gouazé V, Liu YY, Prickett CS, Yu JY, Giuliano AE, Cabot MC.

Cancer Res. 2005 May 1;65(9):3861-7.

13.

[Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR].

Cui XY, Guo YJ, Yao HR.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Oct;28(10):1813-5. Chinese.

14.

[miR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1].

Li X, Zhao J, Tang J.

Zhonghua Zhong Liu Za Zhi. 2014 Dec;36(12):892-6. Chinese.

PMID:
25623761
15.

Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells.

Liu YY, Han TY, Yu JY, Bitterman A, Le A, Giuliano AE, Cabot MC.

J Lipid Res. 2004 May;45(5):933-40. Epub 2004 Feb 16.

16.
17.
18.

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.

Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y.

Breast Cancer Res. 2001;3(4):253-63. Epub 2001 Apr 2.

19.

[Experimental study of adenovirus-mediated p53 gene on the reversal of multidrug resistance in breast cancer].

He SZ, Qi XD, Zhang XM, Wang Y.

Zhonghua Yi Xue Za Zhi. 2007 Nov 6;87(41):2935-7. Chinese.

PMID:
18261311
20.

Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.

Zhou S, Li J, Xu H, Zhang S, Chen X, Chen W, Yang S, Zhong S, Zhao J, Tang J.

Gene. 2017 Jul 30;622:1-12. doi: 10.1016/j.gene.2017.04.026. Epub 2017 Apr 18.

PMID:
28431975

Supplemental Content

Support Center